Bank of America Corp DE Has $83.43 Million Stake in Encompass Health Corporation $EHC

Bank of America Corp DE lowered its position in shares of Encompass Health Corporation (NYSE:EHC) by 10.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 862,512 shares of the company’s stock after selling 98,672 shares during the quarter. Bank of America Corp DE’s holdings in Encompass Health were worth $83,431,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of EHC. Northwestern Mutual Wealth Management Co. raised its position in shares of Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after acquiring an additional 3,793,358 shares in the last quarter. Norges Bank acquired a new stake in Encompass Health during the fourth quarter worth approximately $133,221,000. Price T Rowe Associates Inc. MD grew its stake in Encompass Health by 24.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after purchasing an additional 948,202 shares during the period. Millennium Management LLC increased its holdings in Encompass Health by 140.0% in the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock worth $155,430,000 after purchasing an additional 713,738 shares in the last quarter. Finally, 8 Knots Management LLC acquired a new position in Encompass Health in the second quarter valued at approximately $78,644,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Encompass Health

In related news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.80% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE EHC opened at $125.39 on Friday. The stock has a market cap of $12.44 billion, a price-to-earnings ratio of 20.42, a PEG ratio of 2.68 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.19. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The firm’s 50-day simple moving average is $106.91 and its 200 day simple moving average is $104.59.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts anticipate that Encompass Health Corporation will post 6.07 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.7%. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio is currently 12.69%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on EHC shares. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research report on Friday, May 22nd. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. UBS Group increased their target price on shares of Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday. Truist Financial lifted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday. Finally, Barclays upped their price objective on shares of Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Encompass Health presently has an average rating of “Moderate Buy” and an average target price of $146.57.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.